The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis

This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjust...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Infect Chemother
Main Authors: Somagutta, Manoj Kumar Reddy, Lourdes Pormento, Maria Kezia, Hamid, Pousette, Hamdan, Alaa, Khan, Muhammad Adnan, Desir, Rockeven, Vijayan, Rupalakshmi, Shirke, Saloni, Jeyakumar, Rishan, Dogar, Zeryab, Makkar, Sarabjot Singh, Guntipalli, Prathima, Ngardig, Ngaba Neguemadji, Nagineni, Manasa Sindhura, Paul, Trissa, Luvsannyam, Enkhmaa, Riddick, Chala, Sanchez-Gonzalez, Marcos A.
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2021
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8258297/
https://ncbi.nlm.nih.gov/pubmed/34216117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3947/ic.2021.0016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados